This course has expired. View available courses.
Medication Management
Optimising IV iron therapy: the importance of a patient-centred approach – ACRRM
Iron deficiency (ID) is the commonest nutritional deficiency in Australia and can adversely affect a patient’s quality of life. The principles of managing ID in primary care include making a confirmed diagnosis, identifying and addressing the underlying cause of ID, and correcting the deficiency with iron replacement therapy. The benefits of iron replacement therapy include […]
DURATION
1.5 hrs
PROFESSION
Physician
# OF CREDITS
1.5
ACCREDITATION
ACRRM
EXPIRY DATE
2022-12-31
Iron deficiency (ID) is the commonest nutritional deficiency in Australia and can adversely affect a patient’s quality of life. The principles of managing ID in primary care include making a confirmed diagnosis, identifying and addressing the underlying cause of ID, and correcting the deficiency with iron replacement therapy. The benefits of iron replacement therapy include improvements in fatigue, general health, mental health and quality of life. Because ID is significantly under-diagnosed in Australia, there is a major opportunity in general practice for individual and population health improvements through increased awareness and testing of ID, in addition to targeted iron supplementation.
This 1.5-hour accredited activity aims to empower GPs to improve ID diagnosis rates thereby increasing access to effective treatment with a focus on applying a person-centred approach to selecting intravenous (IV) iron replacement therapy and individualising dosing to ensure adequate iron repletion. It features two cases studies and expert video interviews from the faculty.
This educational activity was developed by MDBriefCase at the request, and with funding from Pfizer.
Faculty
Professor Alhossain Khalafallah (Haematologist)
Dr Sandra Minck (GP)
Learning objectives
On completion of this program, GPs will be better able to:
- Recognise the scale and extent of impact that iron deficiency (ID) and iron deficiency anaemia (IDA) has in the community, particular in certain subgroups
- Identify patients at high risk of ID, including IDA, to improve diagnosis rates and access to effective treatment
- Design an individualised approach to selecting IV iron replacement therapy based on optimising patient outcomes through defined targets
- Determine and assess strategies to optimise tolerability and safety of IV iron replacement therapy
Accreditation
This PDP Activity is accredited by The Australian College of Rural & Remote Medicine for 1 hour of Educational Activity and 0.5 hours of Performance Review.
Activity no. 25012